82 is the total number of securities Velan Capital Investment Management LP has owned. The longest Velan Capital Investment Management LP has owned a single stock is 8 quarters.
| Period | Weighting | Quarter | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Ticker | Name | Longest | Shortest | Min. | Avg. | Max. | First | Latest | ↓ Count |
| LNTH | LANTHEUS HLDGS INC | 8 | 8 | 4.20% | 11.45% | 17.99% | Q4 2021 | Q3 2023 | 8 |
| ADMA | ADMA BIOLOGICS INC | 8 | 8 | 5.01% | 10.01% | 13.71% | Q4 2021 | Q3 2023 | 8 |
| JASPER THERAPEUTICS INC | 8 | 8 | 1.21% | 9.11% | 17.81% | Q4 2021 | Q3 2023 | 8 | |
| TELA | TELA BIO INC | 8 | 8 | 2.98% | 5.48% | 7.58% | Q4 2021 | Q3 2023 | 8 |
| RZLT | REZOLUTE INC | 8 | 8 | 0.43% | 0.87% | 1.31% | Q4 2021 | Q3 2023 | 8 |
| OPTN | OPTINOSE INC | 7 | 7 | 3.57% | 5.58% | 7.90% | Q1 2022 | Q3 2023 | 7 |
| IMCR | IMMUNOCORE HLDGS PLC | 6 | 6 | 7.80% | 9.92% | 13.66% | Q4 2021 | Q1 2023 | 6 |
| ALIMERA SCIENCES INC | 6 | 6 | 0.46% | 6.96% | 34.02% | Q2 2022 | Q3 2023 | 6 | |
| QIPT | QUIPT HOME MEDICAL CORP | 6 | 6 | 1.42% | 3.69% | 4.81% | Q2 2022 | Q3 2023 | 6 |
| CSU | SONIDA SENIOR LIVING INC | 6 | 6 | 0.48% | 1.48% | 2.55% | Q4 2021 | Q1 2023 | 6 |
| HCSG | HEALTHCARE SVCS GROUP INC | 5 | 5 | 1.35% | 2.60% | 4.80% | Q4 2021 | Q4 2022 | 5 |
| HRTX | HERON THERAPEUTICS INC | 4 | 4 | 4.85% | 5.49% | 5.80% | Q4 2022 | Q3 2023 | 4 |
| THE ONCOLOGY INSTITUTE... | 4 | 4 | 2.52% | 3.53% | 4.54% | Q4 2021 | Q3 2022 | 4 | |
| THC | TENET HEALTHCARE CORP | 4 | 4 | 1.32% | 2.51% | 3.92% | Q4 2022 | Q3 2023 | 4 |
| CFMS | CONFORMIS INC | 4 | 4 | 0.98% | 1.99% | 2.69% | Q4 2021 | Q3 2022 | 4 |
| NYXOAH S A | 4 | 4 | 0.49% | 1.85% | 3.17% | Q4 2021 | Q3 2022 | 4 | |
| EDSA | EDESA BIOTECH INC | 4 | 4 | 0.65% | 1.08% | 1.70% | Q4 2022 | Q3 2023 | 4 |
| RDUS | RADIUS HEALTH INC | 3 | 3 | 1.48% | 10.59% | 18.63% | Q4 2021 | Q2 2022 | 3 |
| SCIENCE 37 HOLDINGS INC | 3 | 3 | 0.45% | 5.96% | 11.61% | Q4 2021 | Q2 2022 | 3 | |
| PRAX | PRAXIS PRECISION MEDIC... | 3 | 3 | 3.58% | 5.42% | 7.15% | Q1 2023 | Q3 2023 | 3 |
| HZNP | HORIZON THERAPEUTICS P... | 3 | 3 | 0.24% | 3.80% | 6.92% | Q2 2022 | Q4 2022 | 3 |
| PNT | POINT BIOPHARMA GLOBAL... | 3 | 3 | 2.88% | 3.04% | 3.18% | Q4 2022 | Q2 2023 | 3 |
| CTLT | CATALENT INC | 3 | 3 | 1.99% | 2.27% | 2.80% | Q4 2022 | Q2 2023 | 3 |
| CABA | CABALETTA BIO INC | 3 | 3 | 1.76% | 2.20% | 3.00% | Q1 2023 | Q3 2023 | 3 |
| MOONLAKE IMMUNOTHERAPE... | 3 | 3 | 0.43% | 1.86% | 2.62% | Q1 2023 | Q3 2023 | 3 | |
| CARIBOU BIOSCIENCES INC | 3 | 3 | 1.16% | 1.81% | 2.47% | Q4 2021 | Q2 2022 | 3 | |
| GERN | GERON CORP | 3 | 3 | 0.56% | 1.40% | 2.32% | Q1 2023 | Q3 2023 | 3 |
| ICOSAVAX INC | 3 | 3 | 0.74% | 1.08% | 1.48% | Q1 2023 | Q3 2023 | 3 | |
| ANNX | ANNEXON INC | 3 | 3 | 0.33% | 0.90% | 1.50% | Q1 2023 | Q3 2023 | 3 |
| XENE | XENON PHARMACEUTICALS INC | 3 | 3 | 0.62% | 0.68% | 0.72% | Q2 2022 | Q4 2022 | 3 |
| COLL | COLLEGIUM PHARMACEUTIC... | 3 | 3 | 0.45% | 0.67% | 0.91% | Q3 2022 | Q1 2023 | 3 |
| GFORWS | GRAF ACQUISITION CORP IV | 3 | 3 | 0.01% | 0.01% | 0.02% | Q4 2021 | Q2 2022 | 3 |
| SOMALOGIC INC | 3 | 3 | 0.00% | 0.00% | 0.01% | Q4 2021 | Q2 2022 | 3 | |
| FEZ | SPDR INDEX SHS FDS | 1 | 1 | 3.83% | 9.54% | 15.26% | Q3 2022 | Q1 2023 | 2 |
| IMGN | IMMUNOGEN INC | 2 | 2 | 2.43% | 2.87% | 3.32% | Q2 2023 | Q3 2023 | 2 |
| RAPT | RAPT THERAPEUTICS INC | 2 | 2 | 2.24% | 2.69% | 3.14% | Q4 2021 | Q1 2022 | 2 |
| BCRX | BIOCRYST PHARMACEUTICA... | 2 | 2 | 2.42% | 2.61% | 2.81% | Q2 2022 | Q3 2022 | 2 |
| GRTX | GALERA THERAPEUTICS INC | 2 | 2 | 2.18% | 2.54% | 2.90% | Q1 2023 | Q2 2023 | 2 |
| INSP | INSPIRE MED SYS INC | 1 | 1 | 2.22% | 2.34% | 2.45% | Q4 2022 | Q3 2023 | 2 |
| NSPR | INSPIREMD INC | 2 | 2 | 2.11% | 2.25% | 2.38% | Q2 2023 | Q3 2023 | 2 |
| SOMALOGIC INC | 2 | 2 | 1.75% | 1.94% | 2.13% | Q4 2021 | Q1 2022 | 2 | |
| CMRX | CHIMERIX INC | 2 | 2 | 1.70% | 1.85% | 2.00% | Q4 2021 | Q1 2022 | 2 |
| ETNB | 89BIO INC | 2 | 2 | 1.28% | 1.48% | 1.67% | Q1 2023 | Q2 2023 | 2 |
| IOVA | IOVANCE BIOTHERAPEUTIC... | 2 | 2 | 1.15% | 1.36% | 1.57% | Q1 2023 | Q2 2023 | 2 |
| BLU | BELLUS HEALTH INC NEW | 2 | 2 | 0.73% | 0.89% | 1.05% | Q3 2022 | Q4 2022 | 2 |
| AVDL | AVADEL PHARMACEUTICALS... | 2 | 2 | 0.20% | 0.87% | 1.53% | Q1 2023 | Q2 2023 | 2 |
| IFRX | INFLARX NV | 2 | 2 | 0.48% | 0.65% | 0.83% | Q2 2023 | Q3 2023 | 2 |
| TERN | TERNS PHARMACEUTICALS INC | 2 | 2 | 0.10% | 0.65% | 1.21% | Q4 2022 | Q1 2023 | 2 |
| CGEM | CULLINAN ONCOLOGY INC | 2 | 2 | 0.50% | 0.52% | 0.55% | Q2 2023 | Q3 2023 | 2 |
| LUMIRADX LTD | 2 | 2 | 0.45% | 0.52% | 0.58% | Q3 2022 | Q4 2022 | 2 | |
| INBX | INHIBRX INC | 2 | 2 | 0.37% | 0.49% | 0.60% | Q2 2023 | Q3 2023 | 2 |
| ELEV | ELEVATION ONCOLOGY INC | 2 | 2 | 0.27% | 0.48% | 0.70% | Q2 2023 | Q3 2023 | 2 |
| QIPT | QUIPT HOME MEDICAL CORP | 2 | 2 | 0.41% | 0.45% | 0.50% | Q2 2023 | Q3 2023 | 2 |
| SPY | SPDR S&P 500 ETF TR | 1 | 1 | 16.89% | 16.89% | 16.89% | Q4 2022 | Q4 2022 | 1 |
| ITCI | INTRA-CELLULAR THERAPI... | 1 | 1 | 6.09% | 6.09% | 6.09% | Q4 2021 | Q4 2021 | 1 |
| ATRS | ANTARES PHARMA INC | 1 | 1 | 5.12% | 5.12% | 5.12% | Q1 2022 | Q1 2022 | 1 |
| XBI | SPDR SER TR | 1 | 1 | 3.77% | 3.77% | 3.77% | Q2 2022 | Q2 2022 | 1 |
| NMTR | 9 METERS BIOPHARMA INC | 1 | 1 | 3.29% | 3.29% | 3.29% | Q4 2021 | Q4 2021 | 1 |
| GOSS | GOSSAMER BIO INC | 1 | 1 | 2.06% | 2.06% | 2.06% | Q3 2023 | Q3 2023 | 1 |
| IMTX | IMMATICS N.V | 1 | 1 | 1.92% | 1.92% | 1.92% | Q4 2022 | Q4 2022 | 1 |
| MEIP | MEI PHARMA INC | 1 | 1 | 1.55% | 1.55% | 1.55% | Q4 2021 | Q4 2021 | 1 |
| APLS | APELLIS PHARMACEUTICAL... | 1 | 1 | 1.53% | 1.53% | 1.53% | Q3 2023 | Q3 2023 | 1 |
| ZYME | ZYMEWORKS INC | 1 | 1 | 1.43% | 1.43% | 1.43% | Q3 2022 | Q3 2022 | 1 |
| SGEN | SEAGEN INC | 1 | 1 | 1.14% | 1.14% | 1.14% | Q4 2022 | Q4 2022 | 1 |
| XERIS BIOPHARMA HOLDIN... | 1 | 1 | 1.02% | 1.02% | 1.02% | Q4 2021 | Q4 2021 | 1 | |
| VTRS | VIATRIS INC | 1 | 1 | 1.01% | 1.01% | 1.01% | Q1 2022 | Q1 2022 | 1 |
| ASLAN PHARMACEUTICALS LTD | 1 | 1 | 0.95% | 0.95% | 0.95% | Q3 2023 | Q3 2023 | 1 | |
| CRIS | CURIS INC | 1 | 1 | 0.92% | 0.92% | 0.92% | Q4 2021 | Q4 2021 | 1 |
| IOVA | IOVANCE BIOTHERAPEUTIC... | 1 | 1 | 0.92% | 0.92% | 0.92% | Q3 2023 | Q3 2023 | 1 |
| THESEUS PHARMACEUTICAL... | 1 | 1 | 0.76% | 0.76% | 0.76% | Q1 2023 | Q1 2023 | 1 | |
| GRAF ACQUISITION CORP IV | 1 | 1 | 0.65% | 0.65% | 0.65% | Q4 2021 | Q4 2021 | 1 | |
| CONFORMIS INC | 1 | 1 | 0.60% | 0.60% | 0.60% | Q4 2022 | Q4 2022 | 1 | |
| AIRSCULPT TECHNOLOGIES... | 1 | 1 | 0.60% | 0.60% | 0.60% | Q2 2023 | Q2 2023 | 1 | |
| CHRS | COHERUS BIOSCIENCES INC | 1 | 1 | 0.58% | 0.58% | 0.58% | Q4 2022 | Q4 2022 | 1 |
| ASRT | ASSERTIO HOLDINGS INC | 1 | 1 | 0.53% | 0.53% | 0.53% | Q3 2022 | Q3 2022 | 1 |
| RDUS | RADIUS HEALTH INC | 1 | 1 | 0.53% | 0.53% | 0.53% | Q2 2022 | Q2 2022 | 1 |
| ENVVENO MEDICAL CORPOR... | 1 | 1 | 0.38% | 0.38% | 0.38% | Q4 2021 | Q4 2021 | 1 | |
| 2SEVENTY BIO INC | 1 | 1 | 0.38% | 0.38% | 0.38% | Q1 2022 | Q1 2022 | 1 | |
| GKOS | GLAUKOS CORP | 1 | 1 | 0.36% | 0.36% | 0.36% | Q3 2022 | Q3 2022 | 1 |
| DISC MEDICINE INC | 1 | 1 | 0.22% | 0.22% | 0.22% | Q1 2023 | Q1 2023 | 1 | |
| BOLT | BOLT BIOTHERAPEUTICS INC | 1 | 1 | 0.17% | 0.17% | 0.17% | Q1 2023 | Q1 2023 | 1 |
| BBIO | BRIDGEBIO PHARMA INC | 1 | 1 | 0.02% | 0.02% | 0.02% | Q4 2021 | Q4 2021 | 1 |
Download | |||||||||
The securities at the top of the list , including LANTHEUS HLDGS INC, ADMA BIOLOGICS INC, and JASPER THERAPEUTICS INC, are the highest-conviction holdings of Velan Capital Investment Management LP.
The conviction is calculated by counting the number of quarters a security has been reported by Velan Capital Investment Management LP. The higher the number, the higher the conviction and longer the holding period.
This page lists all the securities that Velan Capital Investment Management LP owns currently or has owned in the past.